tavalisse

Generic: fostamatinib

Labeler: rigel pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tavalisse
Generic Name fostamatinib
Labeler rigel pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

fostamatinib 150 mg/1

Manufacturer
Rigel Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 71332-002
Product ID 71332-002_78828503-b88f-4e3d-9add-8b738c4cf28e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA209299
Listing Expiration 2026-12-31
Marketing Start 2018-05-09

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71332002
Hyphenated Format 71332-002

Supplemental Identifiers

RxCUI
2044922 2044928 2044930 2044932
UNII
SQ8A3S5101

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tavalisse (source: ndc)
Generic Name fostamatinib (source: ndc)
Application Number NDA209299 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71332-002-01)
source: ndc

Packages (1)

71332-002-01 60 TABLET in 1 BOTTLE (71332-002-01)

Ingredients (1)

fostamatinib (150 mg/1)

Linked Drug Pages (1)

TAVALISSE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "78828503-b88f-4e3d-9add-8b738c4cf28e", "openfda": {"unii": ["SQ8A3S5101"], "rxcui": ["2044922", "2044928", "2044930", "2044932"], "spl_set_id": ["21149cc3-049b-43e2-b141-c9499160556c"], "manufacturer_name": ["Rigel Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71332-002-01)", "package_ndc": "71332-002-01", "marketing_start_date": "20180509"}], "brand_name": "TAVALISSE", "product_id": "71332-002_78828503-b88f-4e3d-9add-8b738c4cf28e", "dosage_form": "TABLET", "product_ndc": "71332-002", "generic_name": "FOSTAMATINIB", "labeler_name": "Rigel Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAVALISSE", "active_ingredients": [{"name": "FOSTAMATINIB", "strength": "150 mg/1"}], "application_number": "NDA209299", "marketing_category": "NDA", "marketing_start_date": "20180509", "listing_expiration_date": "20261231"}